(Stroke. 2005;36:1283.)
© 2005 American Heart Association, Inc.
Research Reports |
From the Department of Medical Informatics (N.B.-O., N.J.C., J.F., D.P., L.A.C.-A.), University of Utah School of Medicine; the Weber State University (N.B.-O.), Ogden, Utah; the Department of Radiology (D.P.), University of Utah School of Medicine; Visiting Scholar in Department of Radiology (J.T.), University of Utah School of Medicine; the Department of Neurosurgery (J.M.), University of Utah School of Medicine; and Ophthalmology-Services (Y.Z., Z.Y., K.Z.), John A. Moran Eye Center, University of Utah School of Medicine.
Correspondence to Lisa Cannon-Albright, 391 Chipeta Way, Suite D, Salt Lake City, UT 84108. E-mail lisa{at}genepi.med.utah.edu
| Abstract |
|---|
|
|
|---|
Methods We have investigated the ELN gene as a potential candidate gene for IA in Utah pedigrees. One IA case from each pedigree, who shared an ELN region haplotype segregating in the pedigree, was screened for mutation. The promoter region, 34 exons, and the 3'UTR (UnTranslated Region) of the ELN gene were screened for variants using DHPLC.
Results Variants were observed in the promoter region, exons 4 and 6, and the 3'UTR. Variants in exon 6 and in one 3'UTR position were unique to Utah. The remaining variants were absent in the controls. There was no evidence for segregation of the ELN variants found in IA cases with the hypothesized chromosome 7 haplotypes segregating in pedigrees.
Conclusion Our analysis does not support ELN as the gene responsible for familial IA in the linked Utah IA pedigrees.
Key Words: aneurysm genetics intracranial aneurysm pedigree
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
The 16 genomic DNA samples were amplified by the polymerase chain reaction using primers corresponding to each of 34 ELN exons and their neighboring intronic regions, and to the promoter and 3'UTR regions described in Onda et al.2 The polymerase chain reaction products were screened for mutations by DHPLC. Potential DNA variants were polymerase chain reaction-amplified and sequenced.8 Variants were considered possible candidates if the mutation was new to, or was significant in, the Japanese study. One affected and the oldest unaffected sibling was screened for a rapid and informal determination of segregation of the variant with IA.
| Results |
|---|
|
|
|---|
|
Because Onda et al2 found no significant difference between controls and affected individuals for the variants in promoter (972 or 1042), intron 4, and 3'UTR (+659), and we observed similar frequencies, no further segregation study was performed on these sites. The 3'UTR (+502) variant, which showed borderline significant difference (P=0.085) in the Japanese study, and the 2 novel variants identified in this study (3'UTR +549 and intron 6 94) were examined by testing one affected and unaffected sibling in each pedigree for segregation with IA.
Neither affected nor unaffected siblings in the single pedigree with the 3'UTR G>A (+549) insertion carried informative haplotypes, so no inference could be made between this mutation and IA. The intron 6 variant was observed in 2 pedigrees (Table); however, the G>A (94) mutation was found only in the unaffected sib of 1 pedigree, and was absent in the 2 individuals from the second pedigree. The 3'UTR (+502 ins A) variant was observed in 3 pedigrees. In the first pedigree, both the affected and the unaffected sibling also carried the variant. In the second pedigree, the 2 affected individuals shared both chromosome 7 haplotypes and the DNA change; the unaffected individual did not have the DNA variation. In the third pedigree, the A insertion was not observed in the affected sibling, and informative unaffected siblings were not available.
| Discussion |
|---|
|
|
|---|
Onda et al2 and Ruigrock et al3 have found significant associations between IA and intron 20/intron 23, and intron 5/intron 22, respectively. Such results, in addition to Farnham et al,7 indicate that regulatory pathways for ELN synthesis and maintenance are likely to be involved in IA, rather than ELN structure. Additional sequencing of regulatory regions should be pursued.
| Acknowledgments |
|---|
Received December 14, 2004; revision received March 1, 2005; accepted March 3, 2005.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Foroud, L. Sauerbeck, R. Brown, C. Anderson, D. Woo, D. Kleindorfer, M. L. Flaherty, R. Deka, R. Hornung, I. Meissner, et al. Genome Screen to Detect Linkage to Intracranial Aneurysm Susceptibility Genes: The Familial Intracranial Aneurysm (FIA) Study Stroke, May 1, 2008; 39(5): 1434 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Ruigrok and G. J.E. Rinkel Genetics of Intracranial Aneurysms Stroke, March 1, 2008; 39(3): 1049 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mineharu, K. Inoue, S. Inoue, S. Yamada, K. Nozaki, N. Hashimoto, and A. Koizumi Model-Based Linkage Analyses Confirm Chromosome 19q13.3 as a Susceptibility Locus for Intracranial Aneurysm Stroke, April 1, 2007; 38(4): 1174 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inoue, Y. Mineharu, S. Inoue, S. Yamada, F. Matsuda, K. Nozaki, K. Takenaka, N. Hashimoto, and A. Koizumi Search on Chromosome 17 Centromere Reveals TNFRSF13B as a Susceptibility Gene for Intracranial Aneurysm: A Preliminary Study Circulation, April 25, 2006; 113(16): 2002 - 2010. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |